Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,... | Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim | NCT02780401 | University of Washington | Active, not recruiting |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline | NCT02134925 | National Cancer Institute (NCI) | Active, not recruiting |